Quantcast
Last updated on April 17, 2014 at 17:30 EDT

Latest Channelopathy Stories

2013-01-16 23:03:36

Jan. 17 Event Will Honor Key Food Chief Executive; Special Guest Mrs. World Queens, NY (PRWEB) January 16, 2013 The Foundation Fighting Blindness, a national nonprofit that drives sight-saving research, will host its 2nd Annual ℠Una Visión Para El Futuro´ (A Vision for the Future) on Thursday, Jan. 17, at Terrace on the Park in Flushing Meadows Park. The event will honor the accomplishments and community involvement of Key Food Chief Executive Dean Janeway, as supermarket...

2013-01-10 16:23:26

SOUTH SAN FRANCISCO, Calif., Jan. 10, 2013 /PRNewswire/ -- KaloBios Pharmaceuticals, Inc. today announced that dosing has begun in a randomized, double-blind, placebo-controlled Phase 2 clinical trial of KB001-A, the company's anti-PcrV Humaneered®, PEGylated monoclonal antibody fragment. The study will investigate the safety and efficacy of intravenously administered KB001-A as a treatment for chronic Pseudomonas aeruginosa (Pa) infection in cystic fibrosis patients. The Phase 2 study...

2012-12-03 12:27:20

Calling for the manufacturer and drug insurance plans to ensure CF patients receive equitable and affordable access to KALYDECO(TM) TORONTO, Dec. 3, 2012 /CNW/ - Health Canada has issued a Notice of Compliance (NOC) for KALYDECO(TM), approving the drug for use in Canada. This gives Canadian cystic fibrosis (CF) patients with the G551D mutation (ages six and older) a chance to gain access to this new, breakthrough treatment. Cystic Fibrosis Canada calls on Vertex Pharmaceuticals Inc....

Herbal Remedy May Help Protect Against Macular Degeneration
2012-11-28 09:03:33

April Flowers for redOrbit.com - Your Universe Online Herbal remedies have been used for thousands of years in Asia and early European cultures. In recent years, Western medicine has shown a renewed interest in herbs for their medicinal qualities, and scientists are now isolating the active compounds in many, documenting their antioxidant and anti-inflammatory activities. A new study led by the Sanford-Burnham Medical Research Institute (Sanford-Burnham) reports that carnosic acid,...

2012-11-06 03:34:34

Genetic testing for a certain mutation in pediatric patients is valuable in determining a cause for unexplained hearing loss, according to a study in the November 2012 issue of Otolaryngology—Head and Neck Surgery. The study's authors state that testing for some of the most common mutations that cause sensorineural hearing loss in a targeted way, rather than through generalized screening of hearing loss patients, yields the best results. University of Miami NIH-funded researchers...

2012-10-24 23:36:56

Medical organizations that make race-based recommendations are misleading some patients about health risks while reinforcing harmful notions about race, argues a Michigan State University professor in a new paper published in the journal Preventive Medicine. While some racial groups are on average more prone to certain diseases than the general population, they contain “islands” of lower risk that medical professionals should acknowledge, said Sean Valles, assistant professor...

2012-10-12 07:23:25

ABBOTT PARK, Ill., Oct. 12, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) announced today the winners of the CFCareForward Thriving Undergraduate and Graduate Scholarship award. Mark Moening, a Virginia Beach, Va. resident, and Wesley McSparin, a native of Paducah, Ky., were unveiled as the 2012 Thriving Undergraduate and Graduate Scholarship recipients, respectively. In celebration of the 20(th) anniversary of the program, the total award is $20,000. Earlier this year, 40 undergraduate and...

2012-10-08 07:23:37

BOULDER, Colo., Oct. 8, 2012 /PRNewswire/ -- N30 Pharmaceuticals, Inc. today announced the addition of Dr. Sherif Gabriel to its senior leadership team. Prior to joining N30 Pharma, Dr. Gabriel was on the faculty of the University of North Carolina Cystic Fibrosis Center, Director of the Cystic Fibrosis Correction Core of the Center, and Associate Professor in the Department of Pediatrics, Division of Pulmonology. Dr. Gabriel's career has revolved around the molecular regulation of ion and...

2012-10-03 10:06:21

Preliminary research finds that for patients with nondystrophic myotonias (NDMs), rare diseases that affect the skeletal muscle and cause functionally limiting stiffness and pain, use of the anti-arrhythmic medication mexiletine resulted in improvement in patient-reported stiffness, according to a preliminary study in the October 3 issue of JAMA. Data on treatment of NDMs are largely anecdotal, consisting of case series and a single-blind, controlled trials of several medications including...

Hearing Loss Gene Discovered
2012-10-01 05:38:50

redOrbit Staff & Wire Reports - Your Universe Online A team of researchers, led by members of the University of Cincinnati (UC) and Cincinnati Children's Hospital Medical Center, have reportedly discovered a new genetic mutation that leads to deafness and hearing loss associated with a relatively rare condition. In a September 30 press release, lead investigator and UC assistant professor of ophthalmology Zubair Ahmed explain that he and his colleagues were "able to pinpoint the...


Latest Channelopathy Reference Libraries

Cystic Fibrosis
2013-07-19 15:03:45

Cystic fibrosis, also called mucoviscidosis, is an autosomal recessive genetic disorder of the viscous secretions in the body. In turn, it effects the lungs, pancreas, liver, and intestines, as well as all other exocrine glands in the body. The most common genetic mutation that causes CF is a deletion of three nucleotides that results in a loss of phenylalanine, an amino acid at the 508th position on the protein. It should be noted, however, that there are over a thousand other mutations that...

More Articles (1 articles) »